Clinical Trial: The Role of the Coagulation Pathways in Recurrent Angioedema
Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional
Official Title: The Role of the Coagulation Pathways in Recurrent Angioedema
Brief Summary: Previous studies reported infraclinical modifications of the homeostasis in chronic urticaria, recurrent idiopathic angioedema and hereditary angioedema. This study aim to compare groups with isolated wheals, isolated angioedema, combination of both and hereditary angioedema in terms of coagulation pathways.
Detailed Summary: Previous studies reported infraclinical modifications of the homeostasis in chronic urticaria, recurrent idiopathic angioedema and hereditary angioedema. This study aim to compare groups with isolated wheals, isolated angioedema, combination of both and hereditary angioedema in terms of coagulation pathways. the main objective is to highlight a difference between the rates of different coagulation factors in the 3 groups presenting different categories of angiodemes patients with a group of patients with isolated superficial chronic urticaria
Sponsor: University Hospital, Montpellier
Current Primary Outcome: Levels of several coagulation pathway markers in each group [ Time Frame: 24 Months ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: University Hospital, Montpellier
Dates:
Date Received: September 2, 2016
Date Started: July 2016
Date Completion: July 2020
Last Updated: January 16, 2017
Last Verified: December 2016